Bioorganic and Medicinal Chemistry Letters p. 2151 - 2156 (1999)
Update date:2022-08-05
Topics:
Hu, Lain-Yen
Ryder, Todd R.
Rafferty, Michael F.
Dooley, David J.
Geer, Joann J.
Lotarski, Susan M.
Miljanich, George P.
Millerman, Elizabeth
Rock, David M.
Stoehr, Sally J.
Szoke, Balazs G.
Taylor, Charles P.
Vartanian, Mark G.
Selective N-type voltage sensitive calcium channel (VSCC) blockers have shown efficacy in several animal models of stroke and pain. In the process of searching for small molecule N-type calcium channel blockers, we have identified a series of N-methyl-N-aralkyl-peptidylamines with potent functional activity at N-type VSCCs. The most active compound discovered in this series is PD 173212 (11, IC50 = 36 nM in the IMR32 assays). SAR and pharmacological evaluation of this series are described.
View MoreContact:+86 021-51698675
Address:1701, Jielong Plaza, No.618 Pingliang Rd, ShangHai,China
Hangzhou Mole's Science & Technology Co.,Ltd.(expird)
Contact:+86-571-56880228
Address:15F Guodu development Building, NO.182 Zhaohui Road
Shanghai Yingrui Biopharma Co., Ltd
Contact:021-3358 8661*8003
Address:shanghai
Chengdu ZY Biochemical Technology Co., LTD
Contact:0086-28-88680086
Address:170 Qingpu Road, Shouan Town, Pujiang County
Shantou Baokang Pharmaceutical Co., Ltd.
Contact:+86-754-88873487
Address:5/F B Block Huangshan Bldg Huangshan Rd Shantou
Doi:10.1002/anie.201005212
(2011)Doi:10.1016/S0040-4039(01)80728-0
(1989)Doi:10.1021/jo102228j
(2011)Doi:10.1016/j.ejmech.2010.11.001
(2011)Doi:10.1016/S0040-4039(01)80781-4
(1989)Doi:10.1134/S1070363210110277
(2010)
